归创通桥医疗科技股份有限公司（股票代码：02190）于2026年3月19日更新翌日披露报表，公告显示公司在当天于香港联交所场内回购1,000股H股，占回购前已发行股本约0.0003%。此次回购每股价格为22港元，合计涉资约22,000港元。回购完成后，公司已发行股份数目为329,403,613股，库存股份增加至6,947,131股。
根据公告，此次回购基于2025年5月30日获通过的购回授权。授权范围内可回购股份数为31,958,111股，截至目前公司已在香港联交所及其他交易所合计回购4,127,500股，约占授权通过当日已发行股本的1.2611%。公司确认，本次交易及相关程序符合香港联交所上市规则及相关法规要求。
公告由董事赵中签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.